. . "Voln\u00E1 n\u00E1dorov\u00E1 DNA v plazm\u011B pacient\u016F s kolorekt\u00E1ln\u00EDm karcinomem: II. Poopera\u010Dn\u00ED sledov\u00E1n\u00ED s z\u00E1chyt relapsu onemocn\u011Bn\u00ED." . "O, P(NS9809)" . . . "9"^^ . . "Ur\u010Den\u00ED stupn\u011B generalizace onemocn\u011Bn\u00ED sledov\u00E1n\u00EDm minim\u00E1ln\u00ED rezidu\u00E1ln\u00ED choroby u pacient\u016F s kolorekt\u00E1ln\u00EDm karcinomem m\u016F\u017Ee b\u00FDt kl\u00ED\u010Dov\u00E9 pro v\u010Dasn\u00E1 rozhodnut\u00ED o dal\u0161\u00ED l\u00E9\u010Db\u011B. V tomto ohledu se jev\u00ED velmi slibn\u011B detekce a kvantifikace cirkuluj\u00EDc\u00EDch n\u00E1dorov\u00FDch bun\u011Bk (circulating tumour cells, CTC) a voln\u00E9 n\u00E1dorov\u00E9 DNA (cell-free DNA, cfDNA)."@cs . "Bene\u0161ov\u00E1, Lucie" . "RIV/26475821:_____/11:#0000085" . . . "Ur\u010Den\u00ED stupn\u011B generalizace onemocn\u011Bn\u00ED sledov\u00E1n\u00EDm minim\u00E1ln\u00ED rezidu\u00E1ln\u00ED choroby u pacient\u016F s kolorekt\u00E1ln\u00EDm karcinomem m\u016F\u017Ee b\u00FDt kl\u00ED\u010Dov\u00E9 pro v\u010Dasn\u00E1 rozhodnut\u00ED o dal\u0161\u00ED l\u00E9\u010Db\u011B. V tomto ohledu se jev\u00ED velmi slibn\u011B detekce a kvantifikace cirkuluj\u00EDc\u00EDch n\u00E1dorov\u00FDch bun\u011Bk (circulating tumour cells, CTC) a voln\u00E9 n\u00E1dorov\u00E9 DNA (cell-free DNA, cfDNA)." . "3"^^ . "239480" . "Voln\u00E1 n\u00E1dorov\u00E1 DNA v plazm\u011B pacient\u016F s kolorekt\u00E1ln\u00EDm karcinomem: II. Poopera\u010Dn\u00ED sledov\u00E1n\u00ED s z\u00E1chyt relapsu onemocn\u011Bn\u00ED."@cs . . . "Free tumor DNA in plasma of patients with colorectal cancer: II. Postoperative monitoring with seizure of relapse."@en . . "[520C33347C08]" . . . "Free tumor DNA in plasma of patients with colorectal cancer: II. Postoperative monitoring with seizure of relapse."@en . "RIV/26475821:_____/11:#0000085!RIV11-MZ0-26475821" . . "Determine the degree of generalization of disorder by monitoring of minimal residual disease can be crucial for timely decisions about further treatment in patients with colorectal cancer . In this respect, it seems very promising to detect and quantify circulating tumor cells (circulating tumor cells, CTC) and free tumor DNA (cell-free DNA cfDNA)."@en . "Bel\u0161\u00E1nov\u00E1, Barbora" . . . . "Voln\u00E1 n\u00E1dorov\u00E1 DNA v plazm\u011B pacient\u016F s kolorekt\u00E1ln\u00EDm karcinomem: II. Poopera\u010Dn\u00ED sledov\u00E1n\u00ED s z\u00E1chyt relapsu onemocn\u011Bn\u00ED."@cs . "Min\u00E1rik, Marek" . . . "cfDNA; kolorekt\u00E1ln\u00ED karcinom; z\u00E1chyt relapsu; plazma"@en . . . "Voln\u00E1 n\u00E1dorov\u00E1 DNA v plazm\u011B pacient\u016F s kolorekt\u00E1ln\u00EDm karcinomem: II. Poopera\u010Dn\u00ED sledov\u00E1n\u00ED s z\u00E1chyt relapsu onemocn\u011Bn\u00ED." . .